oteseconazole

oteseconazole

oteseconazole Mycovia Pharmaceuticals Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis  DURHAM, N.C.–(BUSINESS…

Read More